Repligen Corp (NAS:RGEN)
$ 168 +2.86 (+1.73%) Market Cap: 9.48 Bil Enterprise Value: 9.36 Bil PE Ratio: 230.14 PB Ratio: 4.49 GF Score: 88/100

Repligen Corporation at Wells Fargo Healthcare Conference Transcript

Sep 09, 2026 / 05:30PM GMT
Release Date Price: $165.05 (-2.06%)
Evan Stampler
Wells Fargo Securities LLC - Equity Analyst

Hi, everyone. Welcome to day 2 of the Wells Fargo Healthcare Conference, good afternoon. We are excited to have Repligen here. We have CEO Olivier Loeillot and CFO Jason Garland. Very excited to have both of you here.

Questions & Answers

Evan Stampler
Wells Fargo Securities LLC - Equity Analyst

And so maybe the best places to start, I think you guys have best organic growth, at least the companies that we cover, 13% in 2Q. Maybe just start there, what's driving the strong growth for you guys, and maybe any kind of puts and takes for the quarter.

Olivier Loeillot
Repligen Corporation - President, Chief Executive Officer

Yeah, thanks for the question, Evan. Obviously very happy about how quarter 2 played out for us. You're right, we grew 13% organic. In fact, the real number was 14%, because we lost a percent on tariff refund. So really a great quarter, which has enabled us to increase our guidance for the full year to 10.5% to 13.5%, midpoint at

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot